Words by Jade Williams
GOLD takes a look back at some of the top news stories from the pharmaceutical industry over the last few months, ranging from the latest in COVID-19 developments and recent drug approvals to standout mergers and acquisitions
23 November
Nykode Therapeutics and Regeneron partner to develop vaccines for cancer and infectious diseases
24 November
The European Commission grants breast cancer drug Trodelvy marketing authorisation
26 November
UKHSA confirms COVID-19 vaccines are safe for pregnant women and offer high levels of protection
2 December
Researchers discover possible trigger for the rare blood clots caused by AstraZeneca’s vaccine
8 December
Gedeon Richter UK acquires marketing authorisation for first transdermal contraceptive in UK
13 December
Pfizer’s atopic dermatitis treatment Cibinqo granted approval from the European Commission
22 December
Oxford and AstraZeneca announce plan to produce updated vaccine targeting Omicron variant
5 January
Pfizer and BioNTech to collaborate on developing first mRNA-based shingles vaccine
6 January
Merck acquires biopharmaceutical CDMO Exelead to strengthen its mRNA offerings
11 January
The European Commission grants approval of cystic fibrosis treatment for six- to 11-year-olds
18 January
NHS launches HEART study – a world-first pilot in genetic testing for common diseases like breast cancer
19 January
AstraZeneca’s Imfinzi drug reduces risk of death in patients with biliary tract cancer
This news round up features in GOLD 20 – read the full issue here.